ADD THIS DRUG TO MY LIST

Select the drug indication to add to your list

ORTHO MICRONOR
Contraception
Compare To Related Drugs
View/Edit/Compare Drugs In My List

Only 4 drugs may be compared at once

Drug Name:

ORTHO MICRONOR Rx

Generic Name and Formulations:
Norethindrone 0.35mg (28 tabs).

Company:
Janssen Pharmaceuticals, Inc.

Therapeutic Use:

Indications for ORTHO MICRONOR:

Oral contraception.

Adult:

Continuous regimen: 1 tab daily.

Children:

Premenarchal: not recommended.

Contraindications:

Known or suspected breast carcinoma. Undiagnosed abnormal genital bleeding. Liver tumors. Acute liver disease. Pregnancy (Cat.X).

Warnings/Precautions:

Cigarette smoking. Ectopic pregnancy (monitor). Increased risk of breast cancer. Do physical exams at least annually. Monitor carbohydrate and lipid metabolism. Discontinue if migraine or other serious headaches occur. Use back-up contraception for 48hrs if taken 3hrs or more late. Nursing mothers: if not exclusively breastfeeding may start 3 weeks after delivery; if fully breastfeeding may start 6 weeks after delivery.

Interactions:

Antagonized by hepatic enzyme-inducing drugs (eg, phenytoin, carbamazepine, barbiturates, rifampin, St. John's Wort, bosentan). May affect lab tests (eg, sex hormone binding globulins, thyroid).

Pharmacological Class:

Progestin.

Adverse Reactions:

Menstrual irregularities, frequent or irregular bleeding, headache, breast tenderness, nausea, dizziness; delayed follicular atresia, ovarian cysts, androgenic effects (rare).

How Supplied:

Pack—1

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs